Neutrophil hitchhiking for nanoparticle delivery to the central nervous system
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · Nanoplatforms for cancer theranostics · Extracellular vesicles in disease
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (100+)
Show source-provided references
1. Oxidative stress and antioxidants in neurodegenerative disorders10.3390/antiox12020517 ↗
2. Neural stem cell therapy for brain disease10.4252/wjsc.v13.i9.1278 ↗
3. Neuroprotective mechanisms of puerarin in central nervous system diseases: update10.14336/AD.2021.1205 ↗
4. Targeting the central nervous system: from synthetic nanoparticles to extracellular vesicles-focus on alzheimer's and Parkinson's disease10.1002/wnan.1898 ↗
5. A review on lactoferrin and central nervous system diseases10.3390/cells10071810 ↗
6. Advances in microfluidic blood–brain barrier (BBB) models10.1016/j.tibtech.2019.04.006 ↗
7. Living cells and cell-derived vesicles: a trojan horse technique for brain delivery10.3390/pharmaceutics15041257 ↗
8. Nanotechnology reinforced neutrophil-based therapeutic strategies for inflammatory diseases therapy10.1016/j.nantod.2022.101577 ↗
9. Living leukocyte-based drug delivery systems
10. Single-atom nanozymes catalytically surpassing naturally occurring enzymes as sustained stitching for brain trauma10.1038/s41467-022-32411-z ↗
11. An oligomeric semiconducting nanozyme with ultrafast electron transfers alleviates acute brain injury10.1126/sciadv.abk1210 ↗
12. Catalytically potent and selective clusterzymes for modulation of neuroinflammation through single-atom substitutions10.1038/s41467-020-20275-0 ↗
13. Atomic engineering of clusterzyme for relieving acute neuroinflammation through lattice expansion10.1021/acs.nanolett.0c05148 ↗
14. Nanozyme-based bandage with single-atom catalysis for brain trauma10.1021/acsnano.9b05075 ↗
15. Catalytic patch with redox Cr/CeO2 nanozyme of noninvasive intervention for brain trauma10.7150/thno.51912 ↗
16. Carbogenic nanozyme with ultrahigh reactive nitrogen species selectivity for traumatic brain injury10.1021/acs.nanolett.9b01333 ↗
17. Redox trimetallic nanozyme with neutral environment preference for brain injury
18. Advanced strategies to evade the mononuclear phagocyte system clearance of nanomaterials10.1002/EXP.20220045 ↗
19. Stealth coating of nanoparticles in drug-delivery systems10.3390/nano10040787 ↗
20. Absorption, distribution, metabolism, and excretion of nanocarriers in vivo and their influences10.1016/j.cis.2020.102261 ↗
21. Mitigation of inflammatory immune responses with hydrophilic nanoparticles10.1002/anie.201710068 ↗
22. Cell membrane-camouflaged nanoparticles for drug delivery10.1016/j.jconrel.2015.07.019 ↗
23. Tumor exosome-based nanoparticles are efficient drug carriers for chemotherapy10.1038/s41467-019-11718-4 ↗
24. Biomimetics in drug delivery systems: a critical review10.1016/j.jconrel.2017.03.026 ↗
25. Recent progress in targeted delivery vectors based on biomimetic nanoparticles10.1038/s41392-021-00631-2 ↗
26. Advances in the delivery systems for oral antibiotics10.1016/j.bmt.2022.11.010 ↗
27. Fabricated technology of biomedical micro-nano hydrogel10.1016/j.bmt.2022.11.012 ↗
28. Designing bioactive micro-/nanomotors for engineered regeneration
29. Ultrasound-trigged micro/nanorobots for biomedical applications
30. Stimuli-responsive silk fibroin for on-demand drug delivery
31. Neuroinflammation and central sensitization in chronic and widespread pain10.1097/ALN.0000000000002130 ↗
32. Oxidative stress and the central nervous system10.1124/jpet.116.237503 ↗
33. Neuroinflammation in the central nervous system: symphony of glial cells10.1002/glia.23571 ↗
34. Role of neuroinflammation in neurodegenerative diseases10.3892/mmr.2016.4948 ↗
35. Neurogenic neuroinflammation: inflammatory CNS reactions in response to neuronal activity10.1038/nrn3617 ↗
36. Role of inflammation, immunity, and oxidative stress in hypertension: new insights and potential therapeutic targets10.3389/fimmu.2022.1098725 ↗
37. Pathophysiology of inflammatory bowel disease: innate immune system10.3390/ijms24021526 ↗
38. Blood-brain-barrier-penetrating albumin nanoparticles for biomimetic drug delivery via albumin-binding protein pathways for antiglioma therapy10.1021/acsnano.6b04268 ↗
39. Biomimetic nanotherapeutics for targeted drug delivery to glioblastoma multiforme10.1002/btm2.10483 ↗
40. Advances in brain delivery systems based on biomimetic nanoparticles10.1002/cnma.202200066 ↗
41. Recent progress in therapeutic strategies and biomimetic nanomedicines based on neutrophils for inflammation treatment10.2217/nnm-2022-0211 ↗
42. Neutrophil-based delivery systems for nanotherapeutics10.1002/smll.201801674 ↗
43. Neutrophil-mediated transport is crucial for delivery of short-circulating magnetic nanoparticles to tumors10.1016/j.actbio.2020.01.011 ↗
44. Research progress of neutrophil-mediated drug delivery strategies for inflammation-related disease10.3390/pharmaceutics15071881 ↗
45. Neutrophil membrane-coated nanoparticles exhibit increased antimicrobial activities in an anti-microbial resistant K. pneumonia infection model10.1016/j.nano.2022.102640 ↗
46. Neutrophils' extracellular trap mechanisms: from physiology to pathology10.3390/ijms232112855 ↗
47. Neutrophil-based drug delivery systems10.1002/adma.201706245 ↗
48. Nano-integrated cascade antioxidases opsonized by albumin bypass the blood–brain barrier for treatment of ischemia-reperfusion injury10.1039/D2BM01401G ↗
49. Conjugation of oxaliplatin with pegylated-nanobody for enhancing tumor targeting and prolonging circulation10.1016/j.jinorgbio.2021.111553 ↗
50. Surface loading of nanoparticles on engineered or natural erythrocytes for prolonged circulation time: strategies and applications10.1038/s41401-020-00606-z ↗
51. Effect of pegylation on pharmaceuticals10.1038/nrd1033 ↗
52. Revolutionizing cancer treatment: the power of cell-based drug delivery systems10.1016/j.jconrel.2023.08.023 ↗
53. Smart transformable nanomedicines for cancer therapy10.1016/j.biomaterials.2021.120737 ↗
54. Neutrophil membranes coated, antibiotic agent loaded nanoparticles targeting to the lung inflammation10.1016/j.colsurfb.2019.110755 ↗
55. Nanoparticles coated with neutrophil membranes can effectively treat cancer metastasis10.1021/acsnano.6b06477 ↗
56. Clinical translation of nanomedicines: challenges, opportunities, and keys10.1016/j.addr.2021.114083 ↗
57. Obstacles and opportunities in a forward vision for cancer nanomedicine10.1038/s41563-021-01047-7 ↗
58. Progress, challenges, and future of nanomedicine10.1016/j.nantod.2020.101008 ↗
59. Cancer nanomedicine10.1038/s41568-022-00496-9 ↗
60. Advanced materials and processing for drug delivery: the past and the future10.1016/j.addr.2012.10.003 ↗
61. Plga-based biodegradable microspheres in drug delivery: recent advances in research and application10.1080/10717544.2021.1938756 ↗
62. Thermo-sensitive polymers in medicine: a review10.1016/j.eurpolymj.2019.05.024 ↗
63. Critical review of biodegradable and bioactive polymer composites for bone tissue engineering and drug delivery applications10.3390/polym13162623 ↗
64. Injection of pegylated liposomes in rats elicits peg-specific igm, which is responsible for rapid elimination of a second dose of pegylated liposomes10.1016/j.jconrel.2006.01.005 ↗
65. Antibiotics armed neutrophils as a potential therapy for brain fungal infection caused by chemotherapy-induced neutropenia10.1016/j.biomaterials.2021.120849 ↗
66. Targeted trapping of endogenous endothelial progenitor cells for myocardial ischemic injury repair through neutrophil-mediated SPIO nanoparticle-conjugated CD34 antibody delivery and imaging10.1016/j.actbio.2022.05.003 ↗
67. Inflammation-targeted delivery of celastrol via neutrophil membrane-coated nanoparticles in the management of acute pancreatitis10.1021/acs.molpharmaceut.8b01342 ↗
68. Blood–brain barrier dynamics to maintain brain homeostasis10.1016/j.tins.2020.12.002 ↗
69. The blood–brain barrier: structure, regulation, and drug delivery10.1038/s41392-023-01481-w ↗
70. Development, maintenance and disruption of the blood-brain barrier10.1038/nm.3407 ↗
71. Neutrophils cross the BBB primarily on transcellular pathways: an in vitro study10.1016/j.brainres.2010.09.076 ↗
72. Neutrophil-biomimetic "nanobuffer" for remodeling the microenvironment in the infarct core and protecting neurons in the penumbra via neutralization of detrimental factors to treat ischemic stroke10.1021/acsami.2c09020 ↗
73. A nanotherapy of octanoic acid ameliorates cardiac arrest/cardiopulmonary resuscitation-induced brain injury via RVG29 and neutrophil membrane-mediated injury relay targeting10.1021/acsnano.2c09931 ↗
74. Biomimetic neutrophil and macrophage dual membrane-coated nanoplatform with orchestrated tumor-microenvironment responsive capability promotes therapeutic efficacy against glioma10.1016/j.cej.2021.133848 ↗
75. Neutrophils: many ways to die10.3389/fimmu.2021.631821 ↗
76. Dual-targeted and MRI-guided photothermal therapy via iron-based nanoparticles-incorporated neutrophils10.1039/D1BM00127B ↗
77. Nanoengineered neutrophils as a cellular sonosensitizer for visual sonodynamic therapy of malignant tumors
78. Enhanced treatment for cerebral ischemia-reperfusion injury of puerarin loading liposomes through neutrophils-mediated targeted delivery10.1007/s12274-021-3395-y ↗
79. Bionic microbubble neutrophil composite for inflammation-responsive atherosclerotic vulnerable plaque pluripotent intervention
80. Mr imaging tracking of inflammation-activatable engineered neutrophils for targeted therapy of surgically treated glioma10.1038/s41467-018-07250-6 ↗
81. Targeting oxidative stress and inflammation to prevent ischemia-reperfusion10.3389/fnmol.2020.00028 ↗
82. Protective effect of hydrogen sulfide on cerebral ischemia-reperfusion injury10.1007/s10571-021-01166-4 ↗
83. Sevoflurane protects against cerebral ischemia/reperfusion injury via microRNA-30c-5p modulating homeodomain-interacting protein kinase 110.1080/21655979.2021.1999551 ↗
84. Rational design of cancer nanomedicine: nanoproperty integration and synchronization10.1002/adma.201606628 ↗
85. The role of neutrophil death in chronic inflammation and cancer10.1038/s41420-020-0255-6 ↗
86. Net release of long-term surviving neutrophils10.3389/fimmu.2022.815412 ↗
87. Eradication of large established tumors by drug-loaded bacterial particles via a neutrophil-mediated mechanism10.1016/j.jconrel.2021.04.015 ↗
88. Trojan horse” salmonella enabling tumor homing of silver nanoparticles via neutrophil infiltration for synergistic tumor therapy and enhanced biosafety10.1021/acs.nanolett.0c03811 ↗
89. Synergistic effect of tumor chemo-immunotherapy induced by leukocyte-hitchhiking thermal-sensitive micelles10.1038/s41467-021-24902-2 ↗
90. Chemotaxis-driven delivery of nano-pathogenoids for complete eradication of tumors post-phototherapy10.1038/s41467-020-14963-0 ↗
91. Convergence of nanomedicine and neutrophils for drug delivery
92. Salmonella-mediated blood-brain barrier penetration, tumor homing and tumor microenvironment regulation for enhanced chemo/bacterial glioma therapy10.1016/j.apsb.2022.09.016 ↗
93. Bacteria-derived outer-membrane vesicles hitchhike neutrophils to enhance ischemic stroke therapy10.1002/adma.202301779 ↗
94. Direct macromolecular drug delivery to cerebral ischemia area using neutrophil-mediated nanoparticles10.7150/thno.19979 ↗
95. Ligustrazine nanoparticle hitchhiking on neutrophils for enhanced therapy of cerebral ischemia-reperfusion injury10.1002/advs.202301348 ↗
96. Neutrophil delivered hollow titania covered persistent luminescent nanosensitizer for ultrosound augmented chemo/immuno glioblastoma therapy10.1002/advs.202004381 ↗
97. Neutrophil-mediated anticancer drug delivery for suppression of postoperative malignant glioma recurrence10.1038/nnano.2017.54 ↗
98. Cell-liposome delivery system based on neuroinflammation to target the amygdala for ameliorating depressive-like behaviors10.1016/j.ijpharm.2023.122724 ↗
99. Surface modification of PGP for a neutrophil-nanoparticle co-vehicle to enhance the anti-depressant effect of baicalein10.1016/j.apsb.2017.11.012 ↗
100. Hesperetin nanoparticle targeting neutrophils for enhanced TBI therapy